HIV-1/HTLV-1 coinfection drives coordinated adaptive and innate immune dysregulation associated with increased risk of disease progression: a pilot exploratory study

Clinical Immunology Communications · Published 2026-06-26 · DOI 10.1016/j.clicom.2026.100136

Free full text

Authors (6)

Cássia Cristina Leal Borges, Dyjaene Oliveira Barbosa, Aline Clara da Silva, Andrea de Sousa Rocha Barreto da Silveira, Roberto José Meyer Nascimento, Alex José Leite Torres

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Borges, C., Barbosa, D., Silva, A., et al. (2026). HIV-1/HTLV-1 coinfection drives coordinated adaptive and innate immune dysregulation associated with increased risk of disease progression: a pilot exploratory study. Clinical Immunology Communications. https://doi.org/10.1016/j.clicom.2026.100136

Related articles

• Gut barrier integrity and systemic immunity: Mechanisms linking microbiota, barrier dysfunction, and extra-intestinal disease · Clinical Immunology Communications · 2025 · Same journal
• Adult-onset combined immunodeficiency associated with primary biliary cholangitis: a case report · Clinical Immunology Communications · 2026 · Same journal
• Single-cell multiomics in clinical immunology: Revolutionizing immune profiling · Clinical Immunology Communications · 2026 · Same journal
• The immunological nexus between inflammatory bowel disease and colorectal cancer: A molecular perspective · Clinical Immunology Communications · 2025 · Same journal
• Immune microenvironment and progress in immunotherapy of cholangiocarcinoma · Clinical Immunology Communications · 2023 · Same journal
• Deficiency of the interleukin-1 receptor antagonist: Characterizing the molecular consequences of loss-of-function IL1RN variants from structural and biochemical evidence · Clinical Immunology Communications · 2025 · Same journal
• Clinical associations of cytopenias in inborn errors of immunity in the USIDNET registry · Clinical Immunology Communications · 2026 · Same journal
• B cell-centric immunosuppressive signature in the peripheral blood of newly diagnosed multiple myeloma · Clinical Immunology Communications · 2025 · Same journal
• Secondary immunodeficiency after B-cell depletion: Mechanisms, clinical manifestations, monitoring, and management · Clinical Immunology Communications · 2026 · Same journal
• Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature · Clinical Immunology Communications · 2024 · Same journal